Evidence map›Paper›PMID 30349599›Full record

ReviewEuropean endocrinology2018

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden.

S Pinar Bilir, Richard Hellmund, Elizabeth Wehler, Huimin Li, Julie Munakata, Mark Lamotte

Open access · diamondAbstract readReview
In one paragraph

Review in European endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Advances in Continuous Glucose Monitoring: Clinical Applications.Endocrinology and metabolism (Seoul, Korea) · 2025
    Review
  5. Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer Perspective.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  6. Review
  7. Article
  8. Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022
    Article
  9. Review
  10. Cost-Effectiveness of the FreeStyle LibreDiabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
  11. Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
  12. Cost Analysis of FreeStyle LibreDiabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

S Pinar BilirIQVIA, San Francisco, CA, US.
Richard HellmundAbbott Diabetes Care, Alameda, CA, US.
Elizabeth WehlerIQVIA, Plymouth Meeting, PA, US.
Huimin LiIQVIA, Fairfax, VA, US.
Julie MunakataIQVIA, San Francisco, CA, US.
Mark LamotteIQVIA Corporate Village, Zaventem, Belgium.
IQVIA (United States) · USDiabetes Care Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flash glucose monitoring, an alternative to traditional self-monitoring of blood glucose (SMBG), prevents hypoglycaemic events without impacting glycated haemoglobin (REPLACE trial). Given the potential benefits, this study assessed the cost-effectiveness of using flash monitoring versus SMBG alone in patients with type 2 diabetes (T2D) receiving intensive insulin treatment in Sweden.

Indexed as

costcost analysiseconomic analysisglucose monitoringType 2 diabetes

Identifiers

PMID30349599
PMCPMC6182927
OpenAlexW2889659549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.